Revision of consolidated earnings forecasts for the second quarter cumulative period and the full year for the fiscal year ending March 2027. Net sales are expected at 133,800 million yen for the second quarter cumulative period, up 10,300 million yen (YoY +8.3%); operating income 13,700 million yen; ordinary income 13,800 million yen; and quarterly net income attributable to owners of parent per share of 89.35 yen. For the full year, net sales are expected at 270,900 million yen; operating income 27,300 million yen; ordinary income 27,000 million yen; net income attributable to owners of parent 22,900 million yen; and per-share net income 158.66 yen. The revisions reflect strong performance in the Safety Systems, Functional Materials, and Pharmaceuticals segments, along with a weaker yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4272","jir_company_name":"\u65e5\u672c\u5316\u85ac\u682a\u5f0f\u4f1a\u793e","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4272-20260803-02.pdf","jir_short_summary":"Revision of consolidated earnings forecasts for the second quarter cumulative period and the full year for the fiscal year ending March 2027. Net sales are expected at 133,800 million yen for the second quarter cumulative period, up 10,300 million yen (YoY +8.3%); operating income 13,700 million yen; ordinary income 13,800 million yen; and quarterly net income attributable to owners of parent per share of 89.35 yen. For the full year, net sales are expected at 270,900 million yen; operating income 27,300 million yen; ordinary income 27,000 million yen; net income attributable to owners of parent 22,900 million yen; and per-share net income 158.66 yen. The revisions reflect strong performance in the Safety Systems, Functional Materials, and Pharmaceuticals segments, along with a weaker yen.","jir_summary":"### Revision of Earnings Guidance\nNihon Kagaku has upwardly revised its consolidated earnings forecast for the second quarter cumulative period and the full year for the fiscal year ending March 2027. Sales are robust in the Safety Systems, Functional Materials, and Pharmaceuticals segments, aided by the depreciation of the yen. For the second quarter cumulative period, net sales are expected to be 133,800 million yen, operating income 13,700 million yen, ordinary income 13,800 million yen, net income attributable to owners of parent 13,100 million yen, and net income per share 89.35 yen. For the full year, net sales are expected to be 270,900 million yen, operating income 27,300 million yen, ordinary income 27,000 million yen, net income attributable to owners of parent 22,900 million yen, and net income per share 158.66 yen.\n\n### Reasons and Outlook\nThe revision for this term reflects strong sales performance in the second quarter cumulative period and the impact of the yen\u2019s depreciation. Overall, it is expected to exceed the previous forecast, though future market conditions could cause variability. The contributions from each segment are noted in the body text, and ongoing performance trends warrant close watch.","jir_financial_highlights":"Net sales: 133,800 \u767e\u4e07\u5186 (+10,300 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nOperating income: 13,700 \u767e\u4e07\u5186 (+1,900 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nOrdinary income: 13,800 \u767e\u4e07\u5186 (+1,900 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nNet income attributable to owners of parent: 13,100 \u767e\u4e07\u5186 (+1,300 \u767e\u4e07\u5186\uff08\u7b2c2\u56db\u534a\u671f\u7d2f\u8a08\uff09)\nNet income per share (quarterly): 89.35\u5186\uff08\u7b2c2\u56db\u534a\u671f\u7d2f\u8a08\uff09 (\u4e0d\u660e)\nNet sales (full year): 270,900 \u767e\u4e07\u5186 (+10,300 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nOperating income (full year): 27,300 \u767e\u4e07\u5186 (+1,900 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nOrdinary income (full year): 27,000 \u767e\u4e07\u5186 (+1,800 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nNet income attributable to owners of parent (full year): 22,900 \u767e\u4e07\u5186 (+600 \u767e\u4e07\u5186\uff08\u524d\u56de\u4e88\u60f3\u6bd4\uff09)\nNet income per share (full year): 158.66\u5186 (\u4e0d\u660e)","jir_category":"","jir_hashtags":"#NihonKagaku, #IR, #JapaneseStocks","jir_key_figures":"Net sales (2Q cumulative) 133,800 million yen\nOperating income (2Q cumulative) 13,700 million yen\nNet income attributable to owners of parent (2Q cumulative) 13,100 million yen","jir_meta_title":"Nihon Kagaku Announces Earnings Guidance Revision | Forecast for FY2027 Upward","jir_meta_description":"Nihon Kagaku raises its earnings guidance for the second quarter cumulative period and full year of the fiscal year ending March 2027. Strong segment performance and yen depreciation support higher sales and profits. Includes detailed figures and comparisons with the previous forecast.","jir_og_title":"Nihon Kagaku Earnings Guidance Revision | Upward Revision","jir_og_description":"Nihon Kagaku upwardly revises its earnings guidance for the fiscal year ending March 2027. Explains second quarter cumulative and full-year figures and the drivers of change.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8762,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-93828","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n